Quanex delivered flat year-over-year sales in Q3, but its results exceeded Wall Street expectations for both revenue and non-GAAP earnings, prompting a significant positive reaction from the market. Management attributed the performance to disciplined operational initiatives, including the resegmentation of its business lines and the accelerated realization of cost synergies from the Tyman acquisition. CEO George Wilson noted, “We established new commercial and operational excellence teams to drive improved performance,” and highlighted ongoing efforts to optimize working capital and enhance free cash flow. Despite persistent demand headwinds, Quanex’s focus on efficiency and process improvements helped support profitability and bolster investor confidence.
Is now the time to buy NX? Find out in our full research report (it’s free for active Edge members).
Quanex (NX) Q3 CY2025 Highlights:
- Revenue: $489.8 million vs analyst estimates of $469.3 million (flat year on year, 4.4% beat)
- Adjusted EPS: $0.83 vs analyst estimates of $0.52 (61.2% beat)
- Adjusted EBITDA: $70.92 million vs analyst estimates of $59.39 million (14.5% margin, 19.4% beat)
- Operating Margin: 8.8%, up from 0.6% in the same quarter last year
- Market Capitalization: $720.8 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Quanex’s Q3 Earnings Call
- Julio Romero (Sidoti): Asked about the extent of the negative EBITDA impact from the Monterrey facility and expectations for normalization. CFO Scott Zuehlke confirmed the Q4 impact was $8 million, with normalization expected after Q1 next year.
- Steven Ramsey (Thompson Research Group): Inquired if any irrational competitive pricing was emerging due to weak demand. CEO George Wilson stated that pricing remained rational, with supply chain reliability prioritized over aggressive discounts.
- Steven Ramsey (Thompson Research Group): Asked which product categories could outperform in a flat market. Wilson highlighted wood components within Custom Solutions as a possible beneficiary if tariffs remain high.
- Reuben Garner (Benchmark): Sought details on internal controls after the Mexico facility issue. Wilson explained a deep review was conducted across all sites, and no systemic risks were found.
- Kevin Gainey (Thompson, Davis & Company): Asked about the pace and structure of further cost synergies. Zuehlke guided for $5–10 million in additional synergies next year, contingent on volume trends.
Catalysts in Upcoming Quarters
Going forward, our analysts will monitor (1) the pace of recovery and stabilization at the Monterrey facility, (2) Quanex’s ability to realize further synergies and operational improvements from the Tyman acquisition, and (3) demand signals from the U.S. housing and repair-and-remodel markets as interest rates and consumer sentiment evolve. Progress on in-sourcing and tariff management will also be important variables.
Quanex currently trades at $15.88, up from $15.08 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
Our Favorite Stocks Right Now
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
